Therapeutic implications and mechanisms of angiogenesis : inhibitors and stimulators /
Therapeutic implications and mechanisms of angiogenesis : inhibitors and stimulators /
editor, Wendy Hori
- San Francisco, CA. : International Business Communications, c1996
- xv, (various pagings) : ill. ; 28 cm.
- IBC's library series .
Includes references
Contents
Section I: Models and mechanisms of angiogenesis
Chapter 1.1: Angiogenesis in physiologic and pathologic processes: orchestration by cells, soluble mediators and matrix molecules
Chapter 1.2: Quantification of angiogenesis inhibitors in animal models
Chapter 1.3: Angiogenesis assays: problems, pitfalls and potentials
Chapter 1.4: Mechanism of wound angiogenesis
Chapter 1.5: Novel and potent antigenic lipids which promote skin graft survival
Chapter 1.6: Yolk sac endothelial stem cells and the del-1 gene: recent discoveries in angiogenesis and potential therapeutic applications
Section II: Angiogenic mechanisms as potential therapeutic targets in cancer, ocular, inflammatory and cardiovascular diseases
Chapter 2.1: What targets, what endpoints for angiogenic modulation?
Chapter 2.2: Repression of vascular endothelial growth factor gene expression by von Hippel-Lindau Tumor suppressor Protein
Chapter 2.3: High angiogenic factor production in human melanoma xenografts is associated with a high vascular density
Chapter 2.4: Flk-1 Antagonists for inhibition of angiogenesis
Chapter 2.5: Identifying inhibitors of receptor / ligand interactions involved in angiogenesis
Chapter 2.6: Angiogenesis in chronic inflammation
Chapter 2.7: Regulation of endothelial cell growth by thrombospondin-1 and lysophosphatidic acid, two products of activated platelets
Angiogenesis
Neovascularization, Pathologic.
WG 502 T398 1996
Includes references
Contents
Section I: Models and mechanisms of angiogenesis
Chapter 1.1: Angiogenesis in physiologic and pathologic processes: orchestration by cells, soluble mediators and matrix molecules
Chapter 1.2: Quantification of angiogenesis inhibitors in animal models
Chapter 1.3: Angiogenesis assays: problems, pitfalls and potentials
Chapter 1.4: Mechanism of wound angiogenesis
Chapter 1.5: Novel and potent antigenic lipids which promote skin graft survival
Chapter 1.6: Yolk sac endothelial stem cells and the del-1 gene: recent discoveries in angiogenesis and potential therapeutic applications
Section II: Angiogenic mechanisms as potential therapeutic targets in cancer, ocular, inflammatory and cardiovascular diseases
Chapter 2.1: What targets, what endpoints for angiogenic modulation?
Chapter 2.2: Repression of vascular endothelial growth factor gene expression by von Hippel-Lindau Tumor suppressor Protein
Chapter 2.3: High angiogenic factor production in human melanoma xenografts is associated with a high vascular density
Chapter 2.4: Flk-1 Antagonists for inhibition of angiogenesis
Chapter 2.5: Identifying inhibitors of receptor / ligand interactions involved in angiogenesis
Chapter 2.6: Angiogenesis in chronic inflammation
Chapter 2.7: Regulation of endothelial cell growth by thrombospondin-1 and lysophosphatidic acid, two products of activated platelets
Angiogenesis
Neovascularization, Pathologic.
WG 502 T398 1996